Time Magazine writes about Gardasil and the efforts of "Anti-vaccine" activists.
Gardasil has been a shot in the arm for pharmaceutical giant Merck. The company had been reeling from the withdrawal of its anti-arthritis drug Vioxx because of increased risk of heart attacks and resulting lawsuits. Now, however, Merck's new vaccine against the human papilloma virus (HPV) — aimed at combating cervical cancer — has been deployed worldwide, earning an estimated $1.5 billion in sales. But the drug is coming under increasing fire from anti-vaccine activists. Already very vocal about childhood innoculations, now they are expressing concern about the effects of Merck's drug on young girls, a primary focus of the company's big ad campaign.
Read the full article HERE.